Study of How Mitapivat Affects Midazolam Blood Levels in Healthy Participants
Status:
COMPLETED
Trial end date:
2024-12-03
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the effect of mitapivat on the single oral dose pharmacokinetics (PK) of midazolam in healthy participants.